# OnCo record insite (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/insite/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "insite", "NCT03686215" ;
  schema:name "INSITE"@en ;
  schema:alternateName "CL0007"@en, "Investigation of Novel Surgical Imaging for Tumor Excision"@en, "LUM Imaging System pivotal"@en ;
  schema:description "In the study behind Lumisight's approval, scanning the lumpectomy cavity with a fluorescent dye found cancer left behind by standard surgery in about one patient in thirteen and spared some women a second operation, with few false signals but a modest hit rate on individual margins."@en ;
  schema:url <https://onco.cc/trials/insite/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03686215>, <https://doi.org/10.1056/EVIDoa2200333> ;
  onco:status "mixed" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/breast-her2-positive/> ;
  onco:technologies <https://onco.cc/technologies/fluorescence-guided-surgery/>, <https://onco.cc/technologies/optical-imaging/> ;
  onco:drugs <https://onco.cc/drugs/pegulicianine/> ;
  onco:companies <https://onco.cc/companies/lumicell/> ;
  onco:terms <https://onco.cc/terms/sensitivity-specificity/>, <https://onco.cc/terms/lumpectomy/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-smith-nejm-evid/> .